Tirzepatide is a groundbreaking therapeutic agent for individuals facing type 2 diabetes. As a dual agonist, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) https://nanahpsz507231.link4blogs.com/61402477/tirzepatide-a-new-frontier-in-diabetes-treatment